1. Home
  2. NINE vs GDTC Comparison

NINE vs GDTC Comparison

Compare NINE & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nine Energy Service Inc.

NINE

Nine Energy Service Inc.

HOLD

Current Price

$0.33

Market Cap

27.5M

Sector

Energy

ML Signal

HOLD

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.58

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NINE
GDTC
Founded
2011
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.5M
24.8M
IPO Year
2018
2023

Fundamental Metrics

Financial Performance
Metric
NINE
GDTC
Price
$0.33
$1.58
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.1M
39.0K
Earning Date
10-30-2025
04-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$571,171,000.00
$573,193.00
Revenue This Year
$4.56
$5.37
Revenue Next Year
$1.41
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.59
63.03
52 Week Low
$0.29
$1.50
52 Week High
$1.78
$4.05

Technical Indicators

Market Signals
Indicator
NINE
GDTC
Relative Strength Index (RSI) 36.72 36.83
Support Level $0.29 $1.53
Resistance Level $0.51 $1.66
Average True Range (ATR) 0.04 0.13
MACD -0.00 -0.01
Stochastic Oscillator 19.37 10.48

Price Performance

Historical Comparison
NINE
GDTC

About NINE Nine Energy Service Inc.

Nine Energy Service Inc is a North American onshore completion and production services provider. It targets unconventional oil and gas resource development. It operates in one segment, Completion Solutions. The Completion Solutions segment offers cementing services; completion tools, including liner hangers and accessories, frac sleeves, fully composite frac plugs, and specialty open hole float equipment and centralizers and other services. It operates in the U.S, Canada, and other countries where majority of the revenue is generated from the United States.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: